Fingerprint
Dive into the research topics of 'Quality of life outcomes for cabozantinib versus everolimus in patients with metastatic renal cell carcinoma: METEOR phase III randomized trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically